Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

Core Insights - Wave Life Sciences Ltd. is set to host a live webcast and conference call on November 10, 2025, at 8:30 a.m. ET to discuss its third quarter 2025 financial results and provide business updates [1] Company Overview - Wave Life Sciences is a clinical-stage biotechnology company focused on RNA medicines aimed at transforming human health [3] - The company's RNA medicines platform, PRISM®, integrates various modalities and chemistry innovations to address both rare and common disorders [3] - Wave's pipeline includes clinical programs targeting alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease, along with several preclinical programs [3] - The company is headquartered in Cambridge, MA, and emphasizes its mission to "Reimagine Possible" in the realm of human health [3]